2008•Xinxueguan kangfu yixue zazhiRequires access

Effect of irbesartan on reverse left ventricular hypertrophy in patients with mild-moderate essential hypertension

Gao Wa

Open publisher page 0 citations

Abstract

Objective:To observe the effect of irbesartan on reverse left ventricular hypertrophy in patients with mild-moderate essential hypertension.Methods:An auto-control open trial was used in the study,the 83 patients with mild-moderate essential hypertension were treated with irbesartan 150mg/d,and were given with 300mg/d if their blood pressure was not decreased effectively after 4 week until 12 weeks.The blood pressure,echocardiogramphy and drug safety were observed.Results:After 12 weeks treatment the blood pressure significantly decreased(P0.05),the IVST,LVPWT and LVMI significantly decreased,the E/A ratio increased(P0.01 all).Conclusion:Irbesartan is an effective and safe drug for treat essential hypertension and reversed left ventricular hypertrophy.

About this research paper

What this paper is about

Objective:To observe the effect of irbesartan on reverse left ventricular hypertrophy in patients with mild-moderate essential hypertension.Methods:An auto-control open trial was used in the study,the 83 patients with mild-moderate essential hypertension were treated with irbesartan 150mg/d,and were given with 300mg/d if their blood pressure was not decreased effectively after 4 week until 12 weeks.The blood pressure,echocardiogramphy and drug safety were observed.Results:After 12 weeks treatment the blood pressure significantly decreased(P0.05),the IVST,LVPWT and LVMI significantly decreased,the E/A ratio increased(P0.01 all).Conclusion:Irbesartan is an effective and safe drug for treat essential hypertension and reversed left ventricular hypertrophy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To observe the effect of irbesartan on reverse left ventricular hypertrophy in patients with mild-moderate essential hypertension.Methods:An auto-control open trial was used in the study,the 83 patients with mild-moderate essential hypertension were treated with irbesartan 150mg/d,and were given with 300mg/d if their blood pressure was not decreased effectively after 4 week until 12 weeks.The blood pressure,echocardiogramphy and drug safety were observed.Results:After 12 weeks treatment the blood pressure significantly decreased(P0.05),the IVST,LVPWT and LVMI significantly decreased,the E/A ratio increased(P0.01 all).Conclusion:Irbesartan is an effective and safe drug for treat essential hypertension and reversed left ventricular hypertrophy.

Key concepts: Irbesartan, Medicine, Left ventricular hypertrophy, Blood pressure, Cardiology, Essential hypertension, Internal medicine, Muscle hypertrophy

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of irbesartan on reverse left ventricular hypertrophy in patients with mild-moderate essential hypertension — Research Paper | ScholarLens